MedTrace Logo

Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)

NCT01283737 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2012-06-26

No results posted yet for this study

Summary

This is a 1:1 randomised pilot study in 30 patients in 1 site in Helsinki, Finland.

The investigators hypothesize that function, pain, type and quality of cartilage in adult patients with osteochondritis dissecans of the knee will be better in the DBX group compared to the mosaicplasty group.

Conditions

  • Osteochondritis Dissecans

Interventions

DEVICE

DBX Putty

OCD of the knee will be treated with DBX Putty

PROCEDURE

Mosaicplasty

Mosaicplasty procedure performed to treat OCD of the knee

Sponsors & Collaborators

  • Synthes GmbH

    lead INDUSTRY

Principal Investigators

  • Jari Salo, MD · Töölö Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01283737 on ClinicalTrials.gov